Latest Articles

For this article, Technology Networks asked a diverse group of academics and industry leaders: How should research funding change to better support innovation? Here’s how current models help – or hinder – their work.

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency and innovation in new therapies.

Presenting at Technology Networks’ Innovations in Disease Modeling 2025 event, Dr. de la Fuente outlined how his lab is using artificial intelligence to reimagine antibiotic discovery – by turning to the human proteome and ancient genomes.

What happens if the US ties drug prices to other nations? Discover how the most-favored-nation policy could shake the global pharmaceutical industry.

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ensure therapeutic quality in biopharmaceutical drug development.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage a patient’s immune system to treat cancer.

Nine scientists from academia and industry offer their take on the crucial skills tomorrow’s scientists will need to thrive in an evolving research landscape, from AI to digital lab fluency.

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.